Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

11 Oct 2021 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release dated October 11, 2021 titled ‘Glenmark launches Tavulus® for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..